Evaluation of genotoxic potential of aspartame

Sushant Kamath, K. Vijaynarayana, D. Prashanth Shetty, Prerana Shetty.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The present study was planned to investigate the genotoxic potential of aspartame. Bone marrow and peripheral blood micronucleus, bone marrow chromosomal aberration and sperm morphology test were conducted. In micronucleus and chromosomal aberration tests the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals. (455 mg/kg, selected on the basis of conversion of human adequate daily intake (ADI) dose which is 50 mg/kg to animal dose). Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Bone marrow slides were prepared at 24, 48 and 72 h respectively in all groups. In sperm morphology test the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals everyday for one week. Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Percentage of micronucleated polychromatic erythrocytes, percentage of total aberrations induced and percentage of abnormal sperms were determined and the results were analyzed by one-way ANOVA followed by Dunnet's test. Aspartame at doses 455, 500 and 1000 mg/kg showed significant (P<0.01) increase in the number of micronucleated polychromatic erythrocytes, total aberrations and abnormal sperms in 24, 48 and 72 h treatments.These results clearly indicate aspartame to be clastogenic.

Original languageEnglish
Pages (from-to)753-769
Number of pages17
JournalPharmacologyonline
Volume1
Publication statusPublished - 2010

Fingerprint

Aspartame
Spermatozoa
Bone Marrow
Chromosome Aberrations
Cyclophosphamide
Erythrocytes
Water
Pharmaceutical Preparations
Analysis of Variance

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

Kamath, S., Vijaynarayana, K., Prashanth Shetty, D., & Shetty., P. (2010). Evaluation of genotoxic potential of aspartame. Pharmacologyonline, 1, 753-769.
Kamath, Sushant ; Vijaynarayana, K. ; Prashanth Shetty, D. ; Shetty., Prerana. / Evaluation of genotoxic potential of aspartame. In: Pharmacologyonline. 2010 ; Vol. 1. pp. 753-769.
@article{8ad4be3d461e4260820272935e537785,
title = "Evaluation of genotoxic potential of aspartame",
abstract = "The present study was planned to investigate the genotoxic potential of aspartame. Bone marrow and peripheral blood micronucleus, bone marrow chromosomal aberration and sperm morphology test were conducted. In micronucleus and chromosomal aberration tests the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals. (455 mg/kg, selected on the basis of conversion of human adequate daily intake (ADI) dose which is 50 mg/kg to animal dose). Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Bone marrow slides were prepared at 24, 48 and 72 h respectively in all groups. In sperm morphology test the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals everyday for one week. Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Percentage of micronucleated polychromatic erythrocytes, percentage of total aberrations induced and percentage of abnormal sperms were determined and the results were analyzed by one-way ANOVA followed by Dunnet's test. Aspartame at doses 455, 500 and 1000 mg/kg showed significant (P<0.01) increase in the number of micronucleated polychromatic erythrocytes, total aberrations and abnormal sperms in 24, 48 and 72 h treatments.These results clearly indicate aspartame to be clastogenic.",
author = "Sushant Kamath and K. Vijaynarayana and {Prashanth Shetty}, D. and Prerana Shetty.",
year = "2010",
language = "English",
volume = "1",
pages = "753--769",
journal = "Pharmacologyonline",
issn = "1827-8620",
publisher = "SILAE (Italo-Latin American Society of Ethnomedicine)",

}

Kamath, S, Vijaynarayana, K, Prashanth Shetty, D & Shetty., P 2010, 'Evaluation of genotoxic potential of aspartame', Pharmacologyonline, vol. 1, pp. 753-769.

Evaluation of genotoxic potential of aspartame. / Kamath, Sushant; Vijaynarayana, K.; Prashanth Shetty, D.; Shetty., Prerana.

In: Pharmacologyonline, Vol. 1, 2010, p. 753-769.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of genotoxic potential of aspartame

AU - Kamath, Sushant

AU - Vijaynarayana, K.

AU - Prashanth Shetty, D.

AU - Shetty., Prerana

PY - 2010

Y1 - 2010

N2 - The present study was planned to investigate the genotoxic potential of aspartame. Bone marrow and peripheral blood micronucleus, bone marrow chromosomal aberration and sperm morphology test were conducted. In micronucleus and chromosomal aberration tests the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals. (455 mg/kg, selected on the basis of conversion of human adequate daily intake (ADI) dose which is 50 mg/kg to animal dose). Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Bone marrow slides were prepared at 24, 48 and 72 h respectively in all groups. In sperm morphology test the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals everyday for one week. Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Percentage of micronucleated polychromatic erythrocytes, percentage of total aberrations induced and percentage of abnormal sperms were determined and the results were analyzed by one-way ANOVA followed by Dunnet's test. Aspartame at doses 455, 500 and 1000 mg/kg showed significant (P<0.01) increase in the number of micronucleated polychromatic erythrocytes, total aberrations and abnormal sperms in 24, 48 and 72 h treatments.These results clearly indicate aspartame to be clastogenic.

AB - The present study was planned to investigate the genotoxic potential of aspartame. Bone marrow and peripheral blood micronucleus, bone marrow chromosomal aberration and sperm morphology test were conducted. In micronucleus and chromosomal aberration tests the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals. (455 mg/kg, selected on the basis of conversion of human adequate daily intake (ADI) dose which is 50 mg/kg to animal dose). Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Bone marrow slides were prepared at 24, 48 and 72 h respectively in all groups. In sperm morphology test the drug was administered in four different doses (250, 455, 500 and 1000 mg/kg) in a single dose (p.o) to four different groups of animals everyday for one week. Cyclophosphamide (CP), single dose was injected (i.p) at 100 mg/kg to one group which was used as a standard and distilled water treated group was maintained as control. Percentage of micronucleated polychromatic erythrocytes, percentage of total aberrations induced and percentage of abnormal sperms were determined and the results were analyzed by one-way ANOVA followed by Dunnet's test. Aspartame at doses 455, 500 and 1000 mg/kg showed significant (P<0.01) increase in the number of micronucleated polychromatic erythrocytes, total aberrations and abnormal sperms in 24, 48 and 72 h treatments.These results clearly indicate aspartame to be clastogenic.

UR - http://www.scopus.com/inward/record.url?scp=77953176280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953176280&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 753

EP - 769

JO - Pharmacologyonline

JF - Pharmacologyonline

SN - 1827-8620

ER -

Kamath S, Vijaynarayana K, Prashanth Shetty D, Shetty. P. Evaluation of genotoxic potential of aspartame. Pharmacologyonline. 2010;1:753-769.